Optics and photonics

Definition

Optics and photonics is the study of the fundamental properties of light and harnessing them in practical applications. Optics and photonics covers the entire electromagnetic spectrum from high-energy gamma rays and X-rays, through the optical regime of ultraviolet, visible, and infrared light, to long-wavelength microwave and radio waves.

Featured

Latest Research and Reviews

  • Research |

    Cryo-electron microscopy analysis of yeast Rad26 bound to RNA polymerase II provides insight into the initiation of the transcription-coupled DNA repair mechanism in eukaryotes.

    • Jun Xu
    • , Indrajit Lahiri
    • , Wei Wang
    • , Adam Wier
    • , Michael A. Cianfrocco
    • , Jenny Chong
    • , Alissa A. Hare
    • , Peter B. Dervan
    • , Frank DiMaio
    • , Andres E. Leschziner
    •  & Dong Wang
  • Research |

    In a step towards hybrid quantum networks, a quantum state can be transferred between two fundamentally different systems—a cold atomic ensemble and a solid-state crystal—by a single photon.

    • Nicolas Maring
    • , Pau Farrera
    • , Kutlu Kutluer
    • , Margherita Mazzera
    • , Georg Heinze
    •  & Hugues de Riedmatten
    Nature 551, 485–488
  • Research | | open

    Target of rapamycin (TOR) kinase operates within two distinct multiprotein complexes named TORC1 and TORC2. Here the authors report a cryo-EM structure of TORC2, establish its subunit organization, providing a rationale for TORC2’s rapamycin insensitivity and the mutually exclusive inclusion of Avo3/Rictor or Raptor within their respective TOR complex.

    • Manikandan Karuppasamy
    • , Beata Kusmider
    • , Taiana M. Oliveira
    • , Christl Gaubitz
    • , Manoel Prouteau
    • , Robbie Loewith
    •  & Christiane Schaffitzel
  • Research | | open

    Targeted delivery of immunomodulatory compounds to defined subsets of endogenous immune cells may improve the efficacy of combination immunotherapies. Here, the authors use PD-1-targeting nanoparticles containing a TGFβ inhibitor or a TLR7/8 agonist to deliver these payloads to T cells or via T cells to the tumor microenvironment, respectively, leading to anti-tumor efficacy in vivo.

    • Daniela Schmid
    • , Chun Gwon Park
    • , Christina A. Hartl
    • , Nikita Subedi
    • , Adam N. Cartwright
    • , Regina Bou Puerto
    • , Yiran Zheng
    • , James Maiarana
    • , Gordon J. Freeman
    • , Kai W. Wucherpfennig
    • , Darrell J. Irvine
    •  & Michael S. Goldberg

News and Comment